Funds holding “Gilead Sciences Inc”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
20 positions across 19 funds, 4 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust Healthcare | Gilead Sciences Inc | 375558103 | EC | 3.68% | $21.1M | Jun 30, 2026 | full (152 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Gilead Sciences Inc | 375558103 | EC | 2.51% | $27.1M | Jun 30, 2026 | full (170 positions) |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Covered Call / Option Income | Gilead Sciences Inc | 375558103 | EC | 1.37% | $21.8M | Jun 30, 2026 | full (228 positions) |
| ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund Covered Call / Option Income | Gilead Sciences Inc | 375558103 | EC | 1.01% | $18.6M | Jun 30, 2026 | full (147 positions) |
| GLV Clough Global Dividend & Income Fund Global Equity | Gilead Sciences Inc | 375558103 | EC | 0.87% | $820K | Jul 31, 2026 | full (104 positions) |
| EVT Eaton Vance Tax-Advantaged Dividend Income Fund U.S. Equity | Gilead Sciences Inc | 375558103 | EC | 0.78% | $24M | Jul 31, 2026 | full (155 positions) |
| JCE Nuveen Core Equity Alpha Fund U.S. Equity | Gilead Sciences Inc | 375558103 | EC | 0.74% | $2.2M | Jun 30, 2026 | full (144 positions) |
| ETB Eaton Vance Tax-Managed Buy-Write Income Fund Covered Call / Option Income | Gilead Sciences Inc | 375558103 | EC | 0.62% | $3.1M | Jun 30, 2026 | full (133 positions) |
| ASG Liberty All Star Growth Fund U.S. Equity | Gilead Sciences Inc | 375558103 | EC | 0.39% | $1.5M | Jun 30, 2026 | full (119 positions) |
| CSQ Calamos Strategic Total Return Fund Multi-Asset | Gilead Sciences Inc | 375558103 | EC | 0.33% | $16.2M | Jul 31, 2026 | full (820 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | GILEAD SCIENCES INC | 375558103 | EC | 0.33% | $758K | Jun 30, 2026 | full (195 positions) |
| ECAT BlackRock ESG Capital Allocation Term Trust U.S. Equity | Gilead Sciences Inc | 375558103 | EC | 0.23% | $3.8M | Jun 30, 2026 | full (1,193 positions) |
| HEQ John Hancock Diversified Income Fund Multi-Asset | Gilead Sciences Inc. | 375558103 | EC | 0.19% | $307K | Jun 30, 2026 | full (654 positions) |
| BCAT BlackRock Capital Allocation Term Trust U.S. Equity | Gilead Sciences Inc | 375558103 | EC | 0.15% | $2.5M | Jun 30, 2026 | full (1,148 positions) |
| GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust Municipal Bonds | GILEAD SCIENCES INC | 37556TAA4 | ABS-O | 0.11% | $423K | May 29, 2026 | full (579 positions) |
| IGI Western Asset Investment Grade Opportunity Trust Investment Grade | GILEAD SCIENCES INC | 375558AS2 | DBT | 0.06% | $61.3K | May 29, 2026 | full (426 positions) |
| PAI Western Asset Investment Grade Income Fund Investment Grade | GILEAD SCIENCES INC | 375558AS2 | DBT | 0.05% | $61.2K | Jun 30, 2026 | full (473 positions) |
| PAI Western Asset Investment Grade Income Fund Investment Grade | GILEAD SCIENCES INC | 375558BD4 | DBT | 0.04% | $44.8K | Jun 30, 2026 | full (473 positions) |
| GAB Gabelli Equity Trust U.S. Equity | GILEAD SCIENCES INC | 375558103 | EC | 0.01% | $322K | Jun 30, 2026 | full (709 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | GILEAD SCIENCES INC | 375558103 | EC | 0.00% | $16.9K | May 29, 2026 | full (1,841 positions) |
Matching position names
Gilead Sciences Inc · 12GILEAD SCIENCES INC · 7Gilead Sciences Inc. · 1
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.